Immuneering logo

Immuneering Share Price (NASDAQ: IMRX)

$5.72

0.12

(2.14%)

Last updated on

Check the interactive Immuneering Stock chart to analyse performance

Immuneering stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.48
    Today's High:$5.74

    Day's Volatility :4.53%

  • 52 Weeks Low:$1.10
    52 Weeks High:$6.18

    52 Weeks Volatility :82.2%

Immuneering Stock Returns

PeriodImmuneering CorpIndex (Russel 2000)
3 Months
204.81%
0.0%
6 Months
285.14%
0.0%
1 Year
371.07%
0.0%
3 Years
-17.99%
-4.1%

Immuneering Corp Key Stats

Check Immuneering key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.6
Open
$5.7
Today's High
$5.74
Today's Low
$5.48
Market Capitalization
$238.8M
Today's Volume
$376.3K
52 Week High
$6.18
52 Week Low
$1.1
Revenue TTM
$455.0
EBITDA
$-63.7M
Earnings Per Share (EPS)
$-1.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-130.47%

Stock Returns calculator for Immuneering Stock including INR - Dollar returns

The Immuneering stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immuneering investment value today

Current value as on today

₹4,78,011

Returns

₹3,78,011

(+378.01%)

Returns from Immuneering Stock

₹3,72,727 (+372.73%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Immuneering Stock

328%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Immuneering Stock from India on INDmoney has increased by 328% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immuneering Corp

  • Name

    Holdings %

  • Vanguard Group Inc

    2.94%

  • Marshall Wace Asset Management Ltd

    1.59%

  • Morgan Stanley - Brokerage Accounts

    1.30%

  • BlackRock Inc

    0.88%

  • SOUTHPORT MANAGEMENT, L.L.C.

    0.68%

  • Geode Capital Management, LLC

    0.63%

Analyst Recommendation on Immuneering Stock

Rating
Trend

Buy

    71%Buy

    28%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Immuneering(by analysts ranked 0 to 5 stars)

Immuneering Share Price Target

What analysts predicted

Upside of 123.78%

Target:

$12.80

Current:

$5.72

Immuneering share price target is $12.80, a slight Upside of 123.78% compared to current price of $5.72 as per analysts' prediction.

Immuneering Stock Insights

  • Price Movement

    In the last 7 days, IMRX stock has moved up by 16.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -94.41M → 726.32K (in $), with an average increase of 13099.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -18.05M → -14.43M (in $), with an average increase of 12.1% per quarter
  • IMRX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 113.8%

Immuneering Technicals Summary

Sell

Neutral

Buy

Immuneering is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Immuneering Corp Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Immuneering Corp logo
69.14%
285.14%
371.07%
-17.99%
-67.6%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Immuneering Corp

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Organization
Immuneering
Employees
54
CEO
Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Industry
Miscellaneous

Key Management of Immuneering Corp

NameTitle
Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Co-Founder, President, CEO & Director
Mr. Robert J. Carpenter M.B.A., M.S.
Co-Founder & Chair Emeritus
Dr. Brett M. Hall Ph.D.
Chief Scientific Officer
Mr. Michael D. Bookman J.D.
Chief Legal Officer & Secretary
Ms. Mallory Morales CPA
Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer
Ms. Paula George CPA
Director of Accounting & Operations and Assistant Corporate Controller
Ms. Leah R. Neufeld
Chief People Officer
Dr. Peter King Ph.D.
Head of Discovery & VP
Dr. Praveen Nair Ph.D.
Head of Translational Pharmacology & VP
Mr. Harold E. Brakewood
Chief Business Officer

Important FAQs about investing in IMRX Stock from India :

What is Immuneering share price today?

Immuneering share price today is $5.72 as on at the close of the market. Immuneering share today touched a day high of $5.74 and a low of $5.48.

What is the 52 week high and 52 week low for Immuneering share?

Immuneering share touched a 52 week high of $6.18 and a 52 week low of $1.10. Immuneering stock price today i.e. is closed at $5.72, lower by 7.44% versus the 52 week high.

How to invest in Immuneering Stock (IMRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immuneering on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immuneering Shares that will get you 0.2622 shares as per Immuneering share price of $5.72 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immuneering Stock (IMRX) from India?

Indian investors can start investing in Immuneering (IMRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Immuneering stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Immuneering share’s latest price of $5.72 as on August 30, 2025 at 1:29 am IST, you will get 1.7483 shares of Immuneering. Learn more about fractional shares .

What are the returns that Immuneering has given to Indian investors in the last 5 years?

Immuneering stock has given -67.6% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?